what is the difference between cryptocurrency and digital currency, Overview

The latest news of personal pension fund, incremental funds are coming!The latest CPI data will be released tonight. The market expects the overall inflation rate to be 2.7%, 0.1 percentage point higher than that in October, and the core inflation rate is expected to be 3.3%, which is the same as that in October. Although the forecast data shows that the suppression of inflation by monetary policy is close to stagnation, it has dropped sharply compared with the previous peak of 9%. At present, the latest FEDWATCH data shows that the possibility of the Fed cutting interest rates next Tuesday is over 80%.21st century business herald reporter learned exclusively from insiders that this week, the personal pension expansion policy will be announced, "the time may be December 12th". It is reported that the investable products included in personal pension may include over-the-counter products tracking nearly 20 broad-based indexes such as Shanghai and Shenzhen 300 Index, CSI 500 Index, CSI 800 Index, GEM Index and Kechuang 50 Index.

A shares: the latest release of Shanghai Stock Exchange! Incremental funds are coming, and it is likely to continue to rise on Thursday!The latest progress of stamp duty in Hong Kong has come!This is a real long-term positive, which is manifested in three aspects: first, it is conducive to attracting investors to invest in the broad-based index through personal pension accounts; Second, it is helpful to inject new long-term funds into the capital market, optimize the investor structure, stabilize the market and promote the healthy development of the capital market; Third, it reflects the care of the regulatory authorities for the capital market and helps to enhance investors' confidence.

Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.Shanghai stock exchange recently released